Age Related Macular Degeneration and Diabetic Retinopathy Drugs Market
1 Study Coverage
1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Introduction
1.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume for the Year 2017-2028
1.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Dynamics
1.5.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Trends
1.5.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
1.5.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
1.5.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Type
2.1.1 Macular Degeneration Drugs
2.1.2 Diabetic Retinopathy Drugs
2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
2.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
2.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Application
3.1.1 50-60 Years Old
3.1.2 60-70 Years Old
3.1.3 Others
3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
3.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
3.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Competitor Landscape by Company
4.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Company
4.1.1 Top Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2017-2022)
4.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Concentration Ratio (CR)
4.2.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in 2021
4.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Company
4.5.1 Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region
5.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.1.5 Novartis Recent Development
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporation Information
7.2.2 Bayer Healthcare Description and Business Overview
7.2.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.2.5 Bayer Healthcare Recent Development
7.3 Roche
7.3.1 Roche Corporation Information
7.3.2 Roche Description and Business Overview
7.3.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.3.5 Roche Recent Development
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Corporation Information
7.4.2 Neurotech Pharmaceuticals Description and Business Overview
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.4.5 Neurotech Pharmaceuticals Recent Development
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporation Information
7.5.2 Regeneron Pharmaceuticals Description and Business Overview
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.5.5 Regeneron Pharmaceuticals Recent Development
7.6 Allergan
7.6.1 Allergan Corporation Information
7.6.2 Allergan Description and Business Overview
7.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.6.5 Allergan Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Chain Analysis
8.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
8.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Mode & Process
8.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Marketing
8.4.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Channels
8.4.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
8.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Trends
Table 3. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
Table 4. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
Table 5. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs as of 2021)
Table 18. Top Players of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
Table 20. Date of International Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 46. Novartis Recent Development
Table 47. Bayer Healthcare Corporation Information
Table 48. Bayer Healthcare Description and Business Overview
Table 49. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Bayer Healthcare Product
Table 51. Bayer Healthcare Recent Development
Table 52. Roche Corporation Information
Table 53. Roche Description and Business Overview
Table 54. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Roche Product
Table 56. Roche Recent Development
Table 57. Neurotech Pharmaceuticals Corporation Information
Table 58. Neurotech Pharmaceuticals Description and Business Overview
Table 59. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Neurotech Pharmaceuticals Product
Table 61. Neurotech Pharmaceuticals Recent Development
Table 62. Regeneron Pharmaceuticals Corporation Information
Table 63. Regeneron Pharmaceuticals Description and Business Overview
Table 64. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Regeneron Pharmaceuticals Product
Table 66. Regeneron Pharmaceuticals Recent Development
Table 67. Allergan Corporation Information
Table 68. Allergan Description and Business Overview
Table 69. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Allergan Product
Table 71. Allergan Recent Development
Table 72. Key Raw Materials Lists
Table 73. Raw Materials Key Suppliers Lists
Table 74. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers List
Table 75. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors List
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Picture
Figure 2. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales 2017-2028 (K MT)
Figure 5. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales 2017-2028 (K MT)
Figure 8. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Report Years Considered
Figure 11. Product Picture of Macular Degeneration Drugs
Figure 12. Product Picture of Diabetic Retinopathy Drugs
Figure 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2017-2028) & (K MT)
Figure 17. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2017-2028) & (K MT)
Figure 23. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of 50-60 Years Old
Figure 26. Product Picture of 60-70 Years Old
Figure 27. Product Picture of Others
Figure 28. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2017-2028) & (K MT)
Figure 32. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2017-2028) & (K MT)
Figure 38. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Value Chain
Figure 74. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Industry Market Size
